top of page
journal

Press Releases

Ordinateur portable et paperasse

Nov 13, 2025

IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery

Nov 3, 2025

IMPLANET announces the success of its capital increase

Oct 9, 2025

Launch of a Capital Increase with Shareholders’ Preferential Subscription Rights (PSR)

Oct 7, 2025

IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26%

Sep 23, 2025

IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System

Sep 16, 2025

IMPLANET Announces First-Half 2025 Results

Jul 15, 2025

IMPLANET announces CFDA approval for its innovative JAZZ range in China

Jul 8, 2025

IMPLANET announces half-year revenue for 2025 up 41% to €5.8 million

Apr 24, 2025

IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics’ Next-Gen Robotic Solutions at AANS in Boston

Apr 14, 2025

Minutes of IMPLANET’s Annual General Meeting held on April 11, 2025

Apr 9, 2025

IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%

Mar 4, 2025

IMPLANET reports its 2024 Full-Year Results

Jan 14, 2025

IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million

Dec 5, 2024

IMPLANET Announces Financing of €2 Million

Oct 8, 2024

IMPLANET announces revenue of €2.3 million as of September 30, 2024, 50% growth

Sep 25, 2024

elliquence and Implanet Form Partnership for US Distribution of Ultrasonic Bone Scalpel Olea in Endoscopic Spine Market

Sep 19, 2024

Implanet to Co-Exhibit Alongside 8i Robotics’ Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago

Sep 10, 2024

IMPLANET announces its 2024 half-year results

Jul 9, 2024

IMPLANET reports revenue of €4.1 million in the first half of 2024

May 13, 2024

IMPLANET receives FDA clearance for its new hybrid fixation system Jazz Spinal System

Apr 25, 2024

Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024

Apr 9, 2024

IMPLANET reports its 2024 First-Quarter Revenue

Mar 6, 2024

IMPLANET reports its 2023 full-year results

Feb 2, 2024

Implanet announces the success of its capital increase

Jan 25, 2024

Implanet announces the appointment of Max W. Painter as Vice-President and General Manager of its US subsidiary

Jan 15, 2024

IMPLANET reports 2023 annual revenue of €7.4 million

Jan 11, 2024

IMPLANET announces its 2024 financial calendar

Jan 4, 2024

Launch of an issue of new shares with preferential subscription rights

Dec 12, 2023

IMPLANET announces the launch of its training program in advance of marketing its JAZZ® range in China

Dec 11, 2023

Validation by Sanyou Medical's Board of Directors of its commitment to subscribe up to €5 million to IMPLANET's planned capital increase

Nov 16, 2023

IMPLANET receives the approval of its shareholders for its planned capital increase

Oct 31, 2023

IMPLANET specifies the terms of its planned capital increase

Oct 17, 2023

IMPLANET announces its 3rd-quarter and 9-month revenue to September 30, 2023

Oct 11, 2023

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

Sep 28, 2023

IMPLANET signs an agreement with Sanyou Medical for a proposed capital increase with preferential subscription rights

Sep 28, 2023

IMPLANET publishes its 2023 half-year results

Jul 11, 2023

IMPLANET reports revenue of €4.3 million in the first half of 2023

May 4, 2023

Minutes of Implanet’s Annual General Meeting held on May 3, 2023

Apr 25, 2023

IMPLANET reports its Q1 2023 revenue

Apr 11, 2023

IMPLANET receives FDA clearance for its Squale anterior cervical cage range

Mar 7, 2023

IMPLANET reports its 2022 financial results

Jan 24, 2023

IMPLANET reports 2022 annual revenue of €8.0 million, up 31%

Dec 14, 2022

2023 Financial Calendar

Nov 28, 2022

IMPLANET signs an exclusive distribution contract for SMTP Technology Co.'s ultrasonic surgical scalpel in France

Nov 16, 2022

IMPLANET signs a distribution agreement with Sanyou Medical in China and a technological partnership for the development of a new product range

Oct 26, 2022

IMPLANET announces 9-month revenue of €6 million as of September 30, 2022, up +37%

Oct 20, 2022

Implanet announces the success of its capital increase

Sep 28, 2022

Launch of an issue of shares with warrants with preferential subscription rights

Sep 20, 2022

IMPLANET publishes its 2022 half-year results

Sep 20, 2022

Partnership with Sanyou Medical: conditions precedent fulfilled

© Implanet 2013 - All rights reserved

Legal notices

Personal Data Protection Policies

bottom of page